Search research articles
Contact Us
Filters
Showing results (1361-1370 of 2,726) with videos related to
Page
of 273
Sort By:
Bioanalysis
|
October 30, 2015
Ionization sources and mass analyzers in MS imaging
Yu-Hsuan Tsai, Robert F Menger, Dieter M Drexler, et al.
Bioanalysis
|
October 28, 2015
Imaging of drug and metabolite distribution by MS: case studies
Nozomi Takai, Yukari Tanaka
Bioanalysis
|
November 7, 2015
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a
Joleen T White, Mary Crossman, Kelly Richter, et al.
Bioanalysis
|
June 18, 2016
The current skills gaps in analytical sciences are failing industry: debate at the 21st International Reid Bioanalytical Forum
Neil Spooner, Timothy Sangster
Bioanalysis
|
May 25, 2016
Advances in bioanalytical techniques to measure steroid hormones in serum
Deborah French
Bioanalysis
|
July 31, 2015
Bioanalytical approaches for characterizing catabolism of antibody-drug conjugates
Ola M Saad, Ben-Quan Shen, Keyang Xu, et al.
Bioanalysis
|
July 31, 2015
Integration of bioanalytical measurements using PK-PD modeling and simulation: implications for antibody-drug conjugate development
Antari Khot, Sharad Sharma, Dhaval K Shah
Bioanalysis
|
August 14, 2015
Scientific or regulated validation: a tiered approach? Meeting report from a joint EBF/DVDMDG workshop
Philip Timmerman, Steve Lowes, Stuart McDougall, et al.
Bioanalysis
|
August 14, 2015
The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis
Remco A Koster, Jan-Willem C Alffenaar, Rixt Botma, et al.
Bioanalysis
|
August 14, 2015
Linearity of chromatographic systems in drug analysis part II: a Monte Carlo justification for the use of nonlinear regressions
John Burrows, Kenneth Watson
Page
of 273
Search research articles
Search
Showing results (1361-1370 of 2,726) with videos related to
Sort By:
Page
of 273
Bioanalysis
|
October 30, 2015
Ionization sources and mass analyzers in MS imaging
Yu-Hsuan Tsai, Robert F Menger, Dieter M Drexler, et al.
Bioanalysis
|
October 28, 2015
Imaging of drug and metabolite distribution by MS: case studies
Nozomi Takai, Yukari Tanaka
Bioanalysis
|
November 7, 2015
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a
Joleen T White, Mary Crossman, Kelly Richter, et al.
Bioanalysis
|
June 18, 2016
The current skills gaps in analytical sciences are failing industry: debate at the 21st International Reid Bioanalytical Forum
Neil Spooner, Timothy Sangster
Bioanalysis
|
May 25, 2016
Advances in bioanalytical techniques to measure steroid hormones in serum
Deborah French
Bioanalysis
|
July 31, 2015
Bioanalytical approaches for characterizing catabolism of antibody-drug conjugates
Ola M Saad, Ben-Quan Shen, Keyang Xu, et al.
Bioanalysis
|
July 31, 2015
Integration of bioanalytical measurements using PK-PD modeling and simulation: implications for antibody-drug conjugate development
Antari Khot, Sharad Sharma, Dhaval K Shah
Bioanalysis
|
August 14, 2015
Scientific or regulated validation: a tiered approach? Meeting report from a joint EBF/DVDMDG workshop
Philip Timmerman, Steve Lowes, Stuart McDougall, et al.
Bioanalysis
|
August 14, 2015
The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis
Remco A Koster, Jan-Willem C Alffenaar, Rixt Botma, et al.
Bioanalysis
|
August 14, 2015
Linearity of chromatographic systems in drug analysis part II: a Monte Carlo justification for the use of nonlinear regressions
John Burrows, Kenneth Watson
Page
of 273